- Home
- CVM vs PMVP Comparison
CVM vs PMVP Comparison
Compare CVM & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- PMVP
- Stock Information
- Founded
- CVM 1983
- PMVP 2013
- Country
- CVM United States
- PMVP United States
- Employees
- CVM N/A
- PMVP N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- CVM Health Care
- PMVP Health Care
- Exchange
- CVM Nasdaq
- PMVP Nasdaq
- Market Cap
- CVM 71.2M
- PMVP 77.4M
- IPO Year
- CVM 1987
- PMVP 2020
- Fundamental
- Price
- CVM $9.91
- PMVP $1.21
- Analyst Decision
- CVM
- PMVP Strong Buy
- Analyst Count
- CVM 0
- PMVP 1
- Target Price
- CVM N/A
- PMVP $5.00
- AVG Volume (30 Days)
- CVM 294.7K
- PMVP 2.6M
- Earning Date
- CVM 08-14-2025
- PMVP 11-06-2025
- Dividend Yield
- CVM N/A
- PMVP N/A
- EPS Growth
- CVM N/A
- PMVP N/A
- EPS
- CVM N/A
- PMVP N/A
- Revenue
- CVM N/A
- PMVP N/A
- Revenue This Year
- CVM N/A
- PMVP N/A
- Revenue Next Year
- CVM N/A
- PMVP N/A
- P/E Ratio
- CVM N/A
- PMVP N/A
- Revenue Growth
- CVM N/A
- PMVP N/A
- 52 Week Low
- CVM $1.98
- PMVP $0.81
- 52 Week High
- CVM $38.70
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- CVM 51.86
- PMVP 42.03
- Support Level
- CVM N/A
- PMVP $1.19
- Resistance Level
- CVM $10.48
- PMVP $1.40
- Average True Range (ATR)
- CVM 1.11
- PMVP 0.16
- MACD
- CVM -0.64
- PMVP -0.04
- Stochastic Oscillator
- CVM 73.74
- PMVP 15.12
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.